These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2525314)

  • 1. Prostaglandins in inflammatory bone pathology: mechanism and therapeutic benefit of etodolac.
    Hayward MA; Howard GA; Neuman RG; Wood DD; Weichman BM; Van Sickle DC
    Agents Actions; 1989 Mar; 26(3-4):310-8. PubMed ID: 2525314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic evaluation of the effects of etodolac in established adjuvant arthritis in rats: evidence for reversal of joint damage.
    Weichman BM; Chau TT; Rona G
    Arthritis Rheum; 1987 Apr; 30(4):466-70. PubMed ID: 2953342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of etodolac, a new nonsteroidal anti-inflammatory drug, in MRL/lpr mice with articular lesions.
    Yoshida-Suzuka H; Nakamura Y; Shibata Y; Kimura K
    Agents Actions; 1991 Jul; 33(3-4):310-3. PubMed ID: 1835269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of long term treatment with etodolac, naproxen and ibuprofen on articular and bone changes associated with adjuvant arthritis in rats.
    Martel RR; Klicius J; Metcalf G; Rona GA
    Agents Actions; 1984 Oct; 15(3-4):403-12. PubMed ID: 6240930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of prostaglandin biosynthesis by etodolac. I. Selective activities in arthritis.
    Neuman RG; Wilson BD; Barkley M; Kimball ES; Weichman BM; Wood DD
    Agents Actions; 1987 Jun; 21(1-2):160-6. PubMed ID: 2957897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of etodolac on articular and bone pathology associated with adjuvant arthritis in rats: a comparison with aspirin and naproxen.
    Martel RR; Klicius J; Metcalf G
    Agents Actions; 1984 Feb; 14(2):257-64. PubMed ID: 6231845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal relationships of the anti-inflammatory effect of etodolac in the adjuvant arthritic rat.
    Lee DK; Chau TT; Weichman BM; Wooley PH
    Proc Soc Exp Biol Med; 1988 Mar; 187(3):273-7. PubMed ID: 2964641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis.
    Taha AS; McLaughlin S; Holland PJ; Kelly RW; Sturrock RD; Russell RI
    Ann Rheum Dis; 1990 Jun; 49(6):354-8. PubMed ID: 2143369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of 4,6-diethyl-1,3,4,5-tetrahydropyrano[4,3-b]indole-4-acetic acid, an isomer of etodolac.
    Hughes P; DeVirgilio J; Humber LG; Chau T; Weichman B; Neuman G
    J Med Chem; 1989 Sep; 32(9):2134-7. PubMed ID: 2527995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological properties of the new non-steroidal anti-inflammatory agent etodolac.
    Inoue K; Fujisawa H; Sasaki Y; Nishimura T; Nishimura I; Inoue Y; Yokota M; Masuda T; Ueda F; Shibata Y
    Arzneimittelforschung; 1991 Mar; 41(3):228-35. PubMed ID: 1651085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
    Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY
    Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic evaluation of etodolac and naproxen, and their relative effects on gastric and duodenal prostaglandins.
    Russell RI
    Rheumatol Int; 1990; 10 Suppl():17-21. PubMed ID: 2150567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoclast-like cells in murine collagen induced arthritis.
    Suzuki Y; Nishikaku F; Nakatuka M; Koga Y
    J Rheumatol; 1998 Jun; 25(6):1154-60. PubMed ID: 9632079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etodolac: effect on prostaglandin concentrations in gastric mucosa of rats.
    Lee D; Dvornik D
    Life Sci; 1985 Mar; 36(12):1157-62. PubMed ID: 3157036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats.
    Tachibana M; Inoue N; Yoshida E; Matsui M; Ukai Y; Yano J
    Pharmacology; 2003 Jun; 68(2):96-104. PubMed ID: 12711837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NE-58095: a diphosphonate which prevents bone erosion and preserves joint architecture in experimental arthritis.
    Francis MD; Hovancik K; Boyce RW
    Int J Tissue React; 1989; 11(5):239-52. PubMed ID: 2517540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etodolac. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain states.
    Balfour JA; Buckley MM
    Drugs; 1991 Aug; 42(2):274-99. PubMed ID: 1717225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of etodolac in subjects with renal impairment.
    Brater DC
    Eur J Rheumatol Inflamm; 1990; 10(1):44-55. PubMed ID: 2146131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theoretical mechanism for the gastrointestinal safety of etodolac: selective sparing of cytoprotective prostaglandins.
    Dvornik D; Lee DK
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():16-24. PubMed ID: 2525980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.